Literature DB >> 14595426

Breaking the pain barrier.

Halina Machelska, Paul A Heppenstall, Christoph Stein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14595426     DOI： 10.1038/nm1103-1353

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

1.  Early Repeated Administration of CXCR4 Antagonist AMD3100 Dose-Dependently Improves Neuropathic Pain in Rats After L5 Spinal Nerve Ligation.

Authors:  Fang Xie; Yun Wang; Xueyang Li; Yu-Chieh Chao; Yun Yue
Journal:  Neurochem Res       Date:  2016-05-11       Impact factor: 3.996

2.  Effects of the local administration of selective mu-, delta-and kappa-opioid receptor agonists on osteosarcoma-induced hyperalgesia.

Authors:  Ana Baamonde; Ana Lastra; Lucía Juárez; Verónica García; Agustín Hidalgo; Luis Menéndez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-11-08       Impact factor: 3.000

3.  Early systemic granulocyte-colony stimulating factor treatment attenuates neuropathic pain after peripheral nerve injury.

Authors:  Po-Kuan Chao; Kwok-Tung Lu; Yun-Lin Lee; Jin-Chung Chen; Hung-Li Wang; Yi-Ling Yang; Mei-Yun Cheng; Ming-Feng Liao; Long-Sun Ro
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

4.  CXCL10 controls inflammatory pain via opioid peptide-containing macrophages in electroacupuncture.

Authors:  Ying Wang; Rebekka Gehringer; Shaaban A Mousa; Dagmar Hackel; Alexander Brack; Heike L Rittner
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.